298 related articles for article (PubMed ID: 24129318)
1. Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period.
Tuv SS; Krabseth H; Karinen R; Olsen KM; Øiestad EL; Vindenes V
Accid Anal Prev; 2014 Jan; 62():26-31. PubMed ID: 24129318
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
Karinen R; Tuv SS; Øiestad EL; Vindenes V
Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.
Dresen S; Kneisel S; Weinmann W; Zimmermann R; Auwärter V
J Mass Spectrom; 2011 Feb; 46(2):163-71. PubMed ID: 21259394
[TBL] [Abstract][Full Text] [Related]
4. Retrospective Analysis of Synthetic Cannabinoid Metabolites in Urine of Individuals Suspected of Driving Impaired.
Davies BB; Bayard C; Larson SJ; Zarwell LW; Mitchell RA
J Anal Toxicol; 2016 Mar; 40(2):89-96. PubMed ID: 26687103
[TBL] [Abstract][Full Text] [Related]
5. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
6. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
[TBL] [Abstract][Full Text] [Related]
7. Blood synthetic cannabinoid concentrations in cases of suspected impaired driving.
Yeakel JK; Logan BK
J Anal Toxicol; 2013 Oct; 37(8):547-51. PubMed ID: 23965292
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of alcohol and drugs among car and van drivers killed in road accidents in Norway: an overview from 2001 to 2010.
Christophersen AS; Gjerde H
Traffic Inj Prev; 2014; 15(6):523-31. PubMed ID: 24867563
[TBL] [Abstract][Full Text] [Related]
9. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
10. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
Kneisel S; Auwärter V
J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood.
Kacinko SL; Xu A; Homan JW; McMullin MM; Warrington DM; Logan BK
J Anal Toxicol; 2011 Sep; 35(7):386-93. PubMed ID: 21871146
[TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of new psychoactive substances in blood samples of German drivers suspected of driving under the influence of drugs.
Fels H; Herzog J; Skopp G; Holzer A; Paul LD; Graw M; Musshoff F
Drug Test Anal; 2020 Oct; 12(10):1470-1476. PubMed ID: 32652866
[TBL] [Abstract][Full Text] [Related]
13. Rapid and sensitive screening and confirmation of thirty-four aminocarbonyl/carboxamide (NACA) and arylindole synthetic cannabinoid drugs in human whole blood.
Tynon M; Homan J; Kacinko S; Ervin A; McMullin M; Logan BK
Drug Test Anal; 2017 Jun; 9(6):924-934. PubMed ID: 27653946
[TBL] [Abstract][Full Text] [Related]
14. Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073.
Cooper ZD; Poklis JL; Liu F
Neuropharmacology; 2018 May; 134(Pt A):92-100. PubMed ID: 29146503
[TBL] [Abstract][Full Text] [Related]
15. Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers.
Salomone A; Luciano C; Di Corcia D; Gerace E; Vincenti M
Drug Test Anal; 2014; 6(1-2):126-34. PubMed ID: 24115381
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic properties of the synthetic cannabinoid JWH-018 and of its metabolites in serum after inhalation.
Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
J Pharm Biomed Anal; 2017 Jun; 140():215-222. PubMed ID: 28365515
[TBL] [Abstract][Full Text] [Related]
17. First nationwide study on driving under the influence of drugs in Switzerland.
Senna MC; Augsburger M; Aebi B; Briellmann TA; Donzé N; Dubugnon JL; Iten PX; Staub C; Sturm W; Sutter K
Forensic Sci Int; 2010 May; 198(1-3):11-6. PubMed ID: 20211534
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
[TBL] [Abstract][Full Text] [Related]
19. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
Hutter M; Kneisel S; Auwärter V; Neukamm MA
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
[TBL] [Abstract][Full Text] [Related]
20. Drugs and driving prior to cannabis legalization: A 5-year review from DECP (DRE) cases in the province of Quebec, Canada.
Vaillancourt L; Viel E; Dombrowski C; Desharnais B; Mireault P
Accid Anal Prev; 2021 Jan; 149():105832. PubMed ID: 33220606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
